Twist Bioscience Corp (TWST) released Loss for its second quarter of -$44.021 million
The company's bottom line totaled -$44.021 million, or -$0.71 per share. This compares with -$39.328 million, or -$0.66 per share, last year.
The company's revenue for the period rose 19.3% to $110.715 million from $92.793 million last year.
Twist Bioscience Corp earnings at a glance (GAAP) :
-Earnings: -$44.021 Mln. vs. -$39.328 Mln. last year.-EPS: -$0.71 vs. -$0.66 last year.-Revenue: $110.715 Mln vs. $92.793 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.